BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 1686239)

  • 41. Generation and functional characterization of arylamine N-acetyltransferase Nat1/Nat2 double-knockout mice.
    Sugamori KS; Wong S; Gaedigk A; Yu V; Abramovici H; Rozmahel R; Grant DM
    Mol Pharmacol; 2003 Jul; 64(1):170-9. PubMed ID: 12815173
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular and genetic analyses of arylamine N-acetyltransferase polymorphism of rabbit liver.
    Sasaki Y; Ohsako S; Deguchi T
    J Biol Chem; 1991 Jul; 266(20):13243-50. PubMed ID: 2071601
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Slow acetylation in mice is caused by a labile and catalytically impaired mutant N-acetyltransferase (NAT2 9).
    De Leon JH; Martell KJ; Vatsis KP; Weber WW
    Drug Metab Dispos; 1995 Dec; 23(12):1354-61. PubMed ID: 8689943
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine induces a higher number of aberrant crypt foci in Fischer 344 (rapid) than in Wistar Kyoto (slow) acetylator inbred rats.
    Purewal M; Velasco M; Fretland AJ; Hein DW; Wargovich MJ
    Cancer Epidemiol Biomarkers Prev; 2000 May; 9(5):529-32. PubMed ID: 10815700
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cloning, expression, and functional characterization of rapid and slow acetylator polymorphic N-acetyl-transferase encoding genes of the Syrian hamster.
    Ferguson RJ; Doll MA; Rustan TD; Hein DW
    Pharmacogenetics; 1996 Feb; 6(1):55-66. PubMed ID: 8845861
    [TBL] [Abstract][Full Text] [Related]  

  • 46. DNA adduct levels in rapid and slow acetylator inbred rats administered 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.
    Fretland AJ; Feng Y; Hein DW
    Proc West Pharmacol Soc; 1997; 40():9-12. PubMed ID: 9436199
    [No Abstract]   [Full Text] [Related]  

  • 47. N-acetylation pharmacogenetics: a gene deletion causes absence of arylamine N-acetyltransferase in liver of slow acetylator rabbits.
    Blum M; Grant DM; Demierre A; Meyer UA
    Proc Natl Acad Sci U S A; 1989 Dec; 86(23):9554-7. PubMed ID: 2594784
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Systemic functional expression of N-acetyltransferase polymorphism in the F344 Nat2 congenic rat.
    Hein DW; Bendaly J; Neale JR; Doll MA
    Drug Metab Dispos; 2008 Dec; 36(12):2452-9. PubMed ID: 18799801
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Polymorphic N-acetylation of 2-aminofluorene by cell-free colon extracts from inbred mice.
    Levy GN; Martell KJ; Weber WW
    Pharmacogenetics; 1993 Apr; 3(2):71-6. PubMed ID: 7686075
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Acetylator status, drug metabolism and disease.
    Pande JN; Pande A; Singh SP
    Natl Med J India; 2003; 16(1):24-6. PubMed ID: 12715953
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Partial separation of allelic forms of N-acetyltransferase from the rabbit liver using a new method of enzyme purification].
    Kabishev AA; Patrushev LI
    Biokhimiia; 1987 May; 52(5):761-71. PubMed ID: 3593799
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Acetylator genotype-dependent N-acetylation of arylamines in vivo and in vitro by hepatic and extrahepatic organ cytosols of Syrian hamsters congenic at the polymorphic acetyltransferase locus.
    Hein DW; Rustan TD; Martin WJ; Bucher KD; Miller LS; Furman EJ
    Arch Toxicol; 1992; 66(2):112-7. PubMed ID: 1605725
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The S-acetyl coenzyme A-dependent metabolic activation of the carcinogen N-hydroxy-2-aminofluorene by human liver cytosol and its relationship to the aromatic amine N-acetyltransferase phenotype.
    Flammang TJ; Yamazoe Y; Guengerich FP; Kadlubar FF
    Carcinogenesis; 1987 Dec; 8(12):1967-70. PubMed ID: 3677322
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rodent models of the human isoniazid-acetylator polymorphism.
    Tannen RH; Weber WW
    Drug Metab Dispos; 1979; 7(5):274-9. PubMed ID: 40765
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Human acetylator genotype: relationship to colorectal cancer incidence and arylamine N-acetyltransferase expression in colon cytosol.
    Rodriguez JW; Kirlin WG; Ferguson RJ; Doll MA; Gray K; Rustan TD; Lee ME; Kemp K; Urso P; Hein DW
    Arch Toxicol; 1993; 67(7):445-52. PubMed ID: 7902079
    [TBL] [Abstract][Full Text] [Related]  

  • 56. N-acetyltransferase 2 (Nat2) polymorphism in the sand rat Psammomys obesus.
    Khelil M; Djerdjouri B; Tayebi B
    Toxicol Mech Methods; 2010 Oct; 20(8):440-4. PubMed ID: 20550432
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Rabbit N-acetyltransferase 2 genotyping method to investigate role of acetylation polymorphism on N- and O-acetylation of aromatic and heterocyclic amine carcinogens.
    Hein DW; Doll MA
    Arch Toxicol; 2017 Sep; 91(9):3185-3188. PubMed ID: 28536864
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Correlation between N-acetyltransferase activities in uroepithelia and in vivo acetylator phenotype.
    Pink JC; Messing EM; Reznikoff CA; Bryan GT; Swaminathan S
    Drug Metab Dispos; 1992; 20(4):559-65. PubMed ID: 1356735
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tissue distribution of N-acetyltransferase 1 and 2 catalyzing the N-acetylation of 4-aminobiphenyl and O-acetylation of N-hydroxy-4-aminobiphenyl in the congenic rapid and slow acetylator Syrian hamster.
    Hein DW; Doll MA; Nerland DE; Fretland AJ
    Mol Carcinog; 2006 Apr; 45(4):230-8. PubMed ID: 16482518
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Acetyltransferases and susceptibility to chemicals.
    Hein DW; Rustan TD; Doll MA; Bucher KD; Ferguson RJ; Feng Y; Furman EJ; Gray K
    Toxicol Lett; 1992 Dec; 64-65 Spec No():123-30. PubMed ID: 1471166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.